期刊文献+

托拉塞米注射液和呋塞米治疗脑卒中后脑水肿的疗效对比观察 被引量:6

Torasemide Injection and Furosemide of the Brain of the Stroke Edema Comparative Study
下载PDF
导出
摘要 目的观察特苏尼(托拉塞米注射液)与呋塞米治疗脑卒中后脑水肿的疗效。方法将我科128例各种原因导致脑卒中后引起脑水肿患者随机分为两组。观察组给与20%甘露醇125ml+特苏尼20mg。对照组给与20%甘露醇125ml+呋塞米20mg。两组均1次/6h,然后逐渐减量。脑出血患者给予止血药物(氨甲环酸);脑梗死者给予扩血管、活血化瘀药物。两组常规给予抗生素预防继发颅内感染,西咪替丁预防和治疗消化道出血、溃疡,加强护理,维持水、电解质平衡及营养支持治疗,同时保持患肢功能体位,加强被动运动,重症者给予心电监护、吸氧、吸痰等,并记录每小时及24h尿量,两组疗程均为14d。结果治疗组疗效优于对照组,差异有统计学意义(P<0.05)。观察组不良反应少,相对比较安全。结论不论从疗效还是安全性来说,特苏尼较呋塞米有更为优越的治疗价值。 Objective Torasemide Injection and Furosemide in stroke compared the effect of the head edema.Methods Collect I branch 128 cases of all causes caused by cerebral edema after stroke patients were randomly divided into two groups:Observation group give 20% mannitol 125 ml+ Torasemide Injection20 mg.Control group give 20% mannitol 125 ml+ Furosemide 20 mg.Both groups q6h,Then gradually reducing.Cerebral hemorrhage patients to stop bleeding drugs,The cerebral infarction to enlarge the blood vessels,For activating blood circulation and eliminating stasis drugs,Two groups of conventional given antibiotics to prevent secondary intracranial infection,cimetidine The prevention and treatment of gastrointestinal bleeding,ulcer,Ulcer intensive care,keep the water,electrolyte balance and nutrition support therapy,and keep the limb function postures,strengthen the passive sport,The critical to remote ecg monitoring,oxygen,sucking phlegm,etc,The critical to remote ecg monitoring,oxygen,sucking phlegm,etc and record every hour and 24 hours of urine,two groups of course are 14 days.Results Effective treatment group was better than control,statistical significance(P〈0.05),The observation group fewer side effects,the relative safety.Conclusion No matter from the curative effect or for safety Furosemide,Torasemide Injection the rice has more superior therapeutic value.
作者 李广文
出处 《临床合理用药杂志》 2013年第3期44-45,共2页 Chinese Journal of Clinical Rational Drug Use
关键词 托拉塞米 呋塞米 脑水肿 治疗结果 Torasemide Furosemide Brain edema Treatment outcome
  • 相关文献

参考文献9

二级参考文献79

  • 1[1][1] Blose JS,Adams KF Jr,Patterson JH. Torsemide:a pyridine-sulfonylurea loop diuretic[J]. Ann Pharmacother, 1995,29(4): 396 - 402.
  • 2[2]Brater DC. Clinical pharmacology of loop diuretics [J]. Drugs,1991,41 (Suppl 3) :S14 - S22.
  • 3[3]Frieder HA,Buckley MM-T. Torasemide-a review of its pharmacology, properties and therapeutic potential [J]. Drugs, 1991,41(1) :S81 - S103.
  • 4[4]Bart WH,Smith HL,Karnes HT,et al.Torasemide dose proportionality of pharmacokinetics and pharmacodynamics [J]. Prog Pharmacol Clin Pharmacol, 1990,8: 29 - 37.
  • 5[5]Fowler SF, Murray KM. Torsemide: A new loop diruetic [J].Am J Health-Syst Pharm, 1995,52(15): 1771 - 1780.
  • 6[6]Knauf H,Spahn H,Mutschler E. The loop diuretic torasemide in chronic renal failure: pharmacokinetics and pharmacodynamics [J]. Drugs, 1991,41 (Suppl 3) :S23 - S34.
  • 7[7]Kido H,Ohtaki Y. Torasemide (LUPRAC) :a review of its pharmacological and clinical profile[J]. Nippon Yakeurigaku Zasshi,2001,118(2):97- 105.
  • 8[8]Kruck F. Acute and long term effects of loop diuretics in heart failure[J]. Drugs, 1991,41 (Suppl 3): S60 - S68.
  • 9[9]Barr WH,Smith HL,Karnes HT,et al. Comparison of bioavailability, pharmacokinetics and pharmacodynamics of torasemide in young and elderly healthy volunteers[J]. Prog Pharmacol Clin Pharmmol, 1990 ;8:15 - 28.
  • 10[10]Schwartz S,Brater DC,Pound D,et al. Bioavailability,pharmacokinetics and pharmacodynamics of torasemide in patients with cirrhosis[J]. Clin Pharmacol Ther, 1993,54(1): 90 - 97.

共引文献43066

同被引文献36

引证文献6

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部